126 related articles for article (PubMed ID: 23174760)
1. Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer.
Zhang Z; Chen X; Chang X; Ye X; Li Y; Cui H
Int J Mol Med; 2013 Jan; 31(1):147-53. PubMed ID: 23174760
[TBL] [Abstract][Full Text] [Related]
2. Human embryonic stem cells--a potential vaccine for ovarian cancer.
Zhang ZJ; Chen XH; Chang XH; Ye X; Li Y; Cui H
Asian Pac J Cancer Prev; 2012; 13(9):4295-300. PubMed ID: 23167331
[TBL] [Abstract][Full Text] [Related]
3. [Controlled live dendritic cell vaccine mediates potent antitumor immune responses].
Kang Y; Xu CJ; Liu XS; Zhang XH; Wu CQ; Zhong CP; Gu JR
Zhonghua Fu Chan Ke Za Zhi; 2004 Oct; 39(10):669-74. PubMed ID: 16144563
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
5. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
6. [Study of the therapeutic effects of costimulatory molecules B7-1 and interleukin 12 modified tumor cells vaccines on ovarian epithelial carcinoma through induction of anti-cancer immunity of the body].
Liang HM; Jiang J; Kong BH; Ma DX; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):354-8. PubMed ID: 12895379
[TBL] [Abstract][Full Text] [Related]
7. Vaccine therapy of established tumors in the absence of autoimmunity.
Hodge JW; Grosenbach DW; Aarts WM; Poole DJ; Schlom J
Clin Cancer Res; 2003 May; 9(5):1837-49. PubMed ID: 12738742
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
[TBL] [Abstract][Full Text] [Related]
10. Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer.
Hamanishi J; Mandai M; Matsumura N; Baba T; Yamaguchi K; Fujii S; Konishi I
Stem Cells; 2010 Jan; 28(1):164-73. PubMed ID: 19911426
[TBL] [Abstract][Full Text] [Related]
11. [Suicidal cancer vaccine enhances anti-tumor immunotherapeutic effect and its safety in the treatment of ovarian cancer].
Kang Y; Xu CJ; Liu XS; Shao ZM; Ou ZL; Luo JM; Wu CQ; Zhong CP; Gu JR
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):654-7. PubMed ID: 17274368
[TBL] [Abstract][Full Text] [Related]
12. Comparative anticancer effects of vaccination and dietary factors on experimentally-induced cancers.
Zusman I
In Vivo; 1998; 12(6):675-89. PubMed ID: 9891232
[TBL] [Abstract][Full Text] [Related]
13. Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells.
Choi HS; Kim H; Won A; Kim JJ; Son CY; Kim KS; Ko JH; Lee MY; Kim CH; Ryu CJ
Cell Tissue Res; 2008 Aug; 333(2):197-206. PubMed ID: 18560898
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer.
Li Y; Zeng H; Xu RH; Liu B; Li Z
Stem Cells; 2009 Dec; 27(12):3103-11. PubMed ID: 19816950
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer.
Wu D; Yu X; Wang J; Hui X; Zhang Y; Cai Y; Ren M; Guo M; Zhao F; Dou J
J Immunol Res; 2019; 2019():9394615. PubMed ID: 31008116
[TBL] [Abstract][Full Text] [Related]
16. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors.
Hung CF; Calizo R; Tsai YC; He L; Wu TC
Vaccine; 2007 Jan; 25(1):127-35. PubMed ID: 16930783
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy to compensate the disadvantages of live vaccine using suicide-gene system and provide better antitumor immunity.
Kang Y; Xu CJ; Wu CQ; Liu XS; Zhong CP; Zhang XH; Qiao SY; Gu JR
Vaccine; 2006 Mar; 24(12):2141-50. PubMed ID: 16368168
[TBL] [Abstract][Full Text] [Related]
19. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
20. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
Ma J; Wang YL; Hu HM; Fox BA; Si LS
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
